Keyphrases
Perinucleolar Compartment
100%
Therapeutic Leads
100%
Anti-metastasis
100%
Phenotypic Markers
100%
Metarrestin
57%
EEF1A2
42%
Metastasis
42%
Malignancy
28%
Patient Outcomes
28%
Complementary Approach
28%
Cancer Metastasis
28%
Pathognomonic
28%
Cancer Complexity
14%
Tumor Compartments
14%
Malignant Properties
14%
Primary Tumor Growth
14%
Cellular Substructure
14%
Cell Malignancy
14%
Cytoxicity
14%
Metastatic Pancreatic Cancer
14%
Transformation Process
14%
In Vitro Migration
14%
High-grade Cancer
14%
Cancer Xenograft Model
14%
In Vitro Invasion
14%
Cancer Tissue
14%
Molecular Targets
14%
Patient Survival
14%
OR Genes
14%
Mouse Tumor Model
14%
Tumor Tissue
14%
Anticancer Drugs
14%
Effective Treatment
14%
Clinical Practice
14%
Gene Products
14%
Nuclear Bodies
14%
High-content Screening
14%
Morphological Changes
14%
Process Understanding
14%
Metastatic Tumor
14%
Cancer Cells
14%
High-throughput Screening
14%
New Therapeutics
14%
Adverse Effects
14%
DNA Binding
14%
Gene Activity
14%
Two-pronged Approach
14%
Tumor Cells
14%
Cancer Cell Lines
14%
Large Array
14%
Chemical Tools
14%
Surrogate Marker
14%
Cancer-specific
14%
Malignant Potential
14%
Long-stay Patients
14%
Disease Progression
14%
In Vivo Validation
14%
Incomplete Understanding
14%
Tumor Inhibition
14%
Oncogenesis
14%
Anticancer Agents
14%
Metastatic Potential
14%
Medicine and Dentistry
Metastatic Carcinoma
100%
Perinucleolar Compartment
100%
Prevalence
57%
Cancer
57%
In Vitro
42%
Malignant Neoplasm
28%
Pathognomonic
28%
Anticarcinogen
28%
Cancer Tissue
14%
Metastasis Potential
14%
Morphology
14%
Disease Exacerbation
14%
Disease Marker
14%
DNA Binding
14%
Tumor Cell
14%
Carcinogenesis
14%
Cancer Cell Line
14%
Primary Tumor
14%
Cancer Inhibition
14%
Gene Activity
14%
Cancer Cell
14%
Pancreas Cancer
14%
Cancer Grading
14%
High Throughput Screening
14%
Gene Product
14%
Cell Line
14%
Xenograft
14%
Adverse Effect
14%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Prevalence
80%
Anticarcinogen
40%
Mouse Model
20%
Molecular Target
20%
High-Throughput Screening
20%
Cancer Drug Development
20%
Pancreas Cancer
20%
Cancer Inhibition
20%
Disease Exacerbation
20%
Disease Marker
20%
Metastasis Potential
20%
Cancer Grading
20%
Carcinogenesis
20%
Primary Tumor
20%
Neoplasm
20%